𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine based combination regimens for treatment of refractory advanced breast cancer

✍ Scribed by Li Che; Li-jun Di; Guo-hong Song; Jun Jia; Jing Yu; Xiao-li Wang; Yu-lin Zhu; Han-fang Jiang; Xu Liang

Book ID
107466929
Publisher
Chinese Anti-Cancer Association
Year
2008
Tongue
English
Weight
433 KB
Volume
20
Category
Article
ISSN
1000-9604

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy for advanced br
Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin
✍ Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 518 KB

Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.